Nanoparticle-Based Drug Delivery
Moving in Nature Communications, bioRxiv, Biotechnology advances, Cancer Cell and Nature Biotechnology.
- Moved, week to 22 Oct 2026
- 0
- Papers in 60 days
- 11
Add Nanoparticle-Based Drug Delivery as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Nanoparticle-Based Drug Delivery
Newest first · last 60 days
Detection of molecular residual disease via circulating tumor DNA identifies high recurrence risk in resectable solid tumor patients, enabling more efficient clinical trials.
Add Nanoparticle-Based Drug Delivery as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6194
- medRxiv1749
- PNAS447
- Sci Adv354
- JAMA268
- Environ Res246
- BMJ196
- Nat Commun173
- Environ Pollution167
- Nature151
- Science141
- Lancet128
- Cell Rep127
- NEJM118
- Plant Cell Environ114
- Applied & Environ Microbio112
- Curr Biol106
- Blood105
Topics moving, week to 22 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Cancer Immunotherapy and Biomarkers5
- Gut microbiota and health5
- Cancer Genomics and Diagnostics4
- Bacteriophages and microbial interactions4
- CAR-T cell therapy research3
- Lung Cancer Treatments and Mutations3
- Liver Disease Diagnosis and Treatment3
- Dementia and Cognitive Impairment Research3